iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...
iRhythm Technologies, Inc. is a key player in the US ambulatory cardiac monitoring market for arrhythmias. The company's Zio monitors utilize advanced AI and machine learning algorithms for the ...
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent ...
SAN FRANCISCO, Nov. 06, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted ...
iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integration The collaboration will expand access to Zio service across the ...
iRhythm Technologies, Inc. has announced findings from the AVALON study, presented at HRS2025, highlighting the effectiveness of its Zio long-term continuous monitoring (LTCM) service in a younger, ...
“As the healthcare system continues to progress towards value-based medicine, we recognize that providers are increasingly challenged to improve clinical outcomes for patients while controlling costs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results